SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GSII - GENERAL SURGICAL INNOVATIONS, INC.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Elroy who wrote (209)8/24/1999 1:38:00 AM
From: Stewart Elliot  Read Replies (1) of 211
 
I'm actually quite upset at this announcement. Tyco got the company way too cheap. It seems to me if GSII waits 3-6 months, they get $12-15+. Why sell out before the upside potential is demonstrated? But, I guess it isn't surprising. GSII has delivered incredibly poor results over the last few years, so why should we expect the management to negotiate a good deal?

We've all bought this speculation for a big upside potential, and what we got is a low-ball sell out. The tyco guys just bought themselves a monopoly, and probably are laughing at how cheap they got the technology.

There better be price protection on this buyout, or every shareholder should vote no (or sue the company). It's bad enough that we've seen such poor results over the years, but this is the ultimate insult. $7.50? Give me a break - what are these guys thinking? If GSII boosts its sales to a run rate of $20MM/year, and receives a fairly reasonable 10x sales (not out of the question, given the monopoly position of the technology), we would see $15/share. Who advised them on this deal? It makes no sense at all.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext